View Older Stories View More Recent Stories
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Civitas Resources
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
-
Trump cuts threaten safety training for workers in America’s most dangerous jobs
-
US court won't lift judge's block on Trump's government overhaul
-
ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
-
Hims to cut 4% of workforce amid ban on weight-loss drug copies
-
CIVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Civitas Resources, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
City Unions Slam Mayor Lurie's Budget: "This is the budget Airbnb wants."
-
Thyssenkrupp putting 20,000 jobs at risk in overhaul, says union
-
nCino Inc. (NCNO) PT Raised to $34 at UBS
-
US inflation tepid in April, consumer spending slows
-
Musk said he was chainsawing government spending. It was more like a trim
-
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
-
Without Musk, DOGE likely to fizzle out, says ex-staffer
-
State Dept overhaul will cut thousands of jobs, push 'Western values'
-
Stealth Bio to cut jobs after FDA rejects therapy for rare disorder
-
Keros Therapeutics (KROS) Announces TROPOS Topline Data and Corporate Restructuring
-
Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring
-
Elon Musk leaving Trump administration, capping turbulent tenure
-
Chevron to cut 200 jobs in Texas
-
Factory that symbolised Nissan's rise may become victim of its decline
-
Trump administration cancels Sunnova's $2.92 billion government loan guarantee
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Civitas Resources, Inc. and Certain Officers – CIVI
-
More than 200 jobs cut at International Labour Organization as US slashes funding
-
'nCino Inc. (NCNO) Announces 7% Workforce Reduction'; KBW Reiterates Outperform Rating
-
WSSA Unveils its Weed Management Priorities Amid Concerning Federal Cost Cuts to Agriculture Research
-
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
-
Leerink Partners Downgrades Boundless Bio Inc. (BOLD) to Market Perform
-
Factbox-Sales, China and US tariffs: challenges for new Stellantis boss
-
Nissan offers buyouts to US workers, halts global pay rises, internal emails show
-
Settlement Agreements Online Offers An Innovative Service For Settlement Agreement Advice
-
Pender Growth Fund Provides Financial Highlights and Company Updates
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
-
Canada's Hudson's Bay retail chain to terminate more than 8,300 workers by Sunday
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Civitas Resources
-
Volvo Cars to slash 3,000 jobs in white-collar cutback
-
OSBCU: Ford’s Status Quo Education Budget Fails Students, Parents, and Workers
-
ROSEN, A LEADING NATIONAL FIRM, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
-
Trump says US will control US Steel as part of Nippon deal
-
CIVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Civitas Resources, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Civitas Resources
-
Prothena Corp. (PRTA) announces Phase 3 trial for Birtamimab did not meet endpoint
-
Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint
-
Boundless Bio Announces Portfolio Prioritization and Runway Extension
-
Trump supports Nippon Steel's bid for US Steel, shares jump 21%
-
French consumer confidence falls unexpectedly to 5-month low in May
-
Inventiva reports 2025 First Quarter Financial Information¹
-
Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025
-
Mexico's Pemex plans restructuring to save costs, document shows

